1Vicari G. Virological Safety Aspects of Plasma Derivatives. Biologicals, 1993, 21(1):85-87.
2Schiff R I. Transmission of viral Infections Through Intravenous Immune Globulin.New Engl J Med, 1994, 331(24): 1649-1650.
3Christopher J H, Nikant K S, Jonnifer D,et al. Outbreak of Actue Hepatitis C Following the Use of Anti - Hepatitis C Virus-Screened Intravenous Immunoglobulin Therapy. Gastroenterology April, 1996,110(4): 1120-1126.
5Behrens, R H, Doherty J F. Severe hepatitis A despite passive immunization. Lancct, 1993, 341:972.
6Werzberger A, Mousch B, Kuter B, et al. A Controlled Trial of Formalin- inactivated Hepatitis A vaccine in healthy Children. N Engl J Med, 1992, 327:453-457.
7Innis B L, Snitbhan R, Kunasol P, et al. Protection Against Hepatitis A by an Inactivated Vaccine. JAMA, 1994, 271:1328 - 1334.
9Prikazsky V, Olcar /,Counocl, A, et al. Interruption of an outbreak of licp-tis A in two villages by vaccination. J Med Virol, 1994, 44:457-459.
10McMahon P J, Beller M. Williams J et al. A Program to control an outbreak of hepatitis A in Alaska using an inactivated hepatitis A vaccine. 34th ICAC, 1994, abstr : H11.
4Feistone S M,Kapikian A Z,Purcell R H.Detection by immune electron microscopy of a virus like antigen associated with acute illness.Science 1973,182:1026-1028.
5Provost P J and Hilleman M R.Propagation of human hepatitis A virus in cell culture in vitro.Proc.Soc Exp Biol Med,1979,160:213-221.
6Biziagos E,Long term survival of HAV and polio type 1 in mineral water (HAV phisical resistance)Appl.Enveromental-Microbiol,1988,54(11):2705-2702.
7Leonicar-G.A prospective study of HAV and the question of chronicity.Hepato-Gastroenterol,1988,35(2):69-72.
8Yap-L,Guan-R,Hepatitis A sero-epidemiology in Singapore.A change pattern,Trans-R-Soc. -Trop.Med,Hyg,1993,87(1):22-23.
